FDA Announces Guidance for Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use

Summary

The Food and Drug Administration (FDA) has released a guidance document outlining studies and criteria for submitting premarket notifications for prescription blood glucose monitoring systems used in professional healthcare settings, aiming to assist manufacturers in conducting performance studies and preparing 510(k) submissions.